Logo image of AYJ.DE

VALNEVA SE (AYJ.DE) Stock Overview

FRA:AYJ - FR0004056851 - Common Stock

3.8 EUR
+0.24 (+6.68%)
Last: 9/9/2025, 7:00:00 PM

AYJ.DE Key Statistics, Chart & Performance

Key Statistics
52 Week High5.31
52 Week Low1.73
Market Cap323.12M
Shares85.03M
Float75.83M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.45
PEN/A
Fwd PEN/A
Earnings (Next)11-20 2025-11-20
IPO06-28 2007-06-28
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


AYJ.DE short term performance overview.The bars show the price performance of AYJ.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40

AYJ.DE long term performance overview.The bars show the price performance of AYJ.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20

The current stock price of AYJ.DE is 3.8 EUR. In the past month the price decreased by -2.56%. In the past year, price increased by 32.59%.

VALNEVA SE / AYJ Daily stock chart

AYJ.DE Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 19.89 316.92B
AMG.DE AMGEN INC 12.95 129.45B
GIS.DE GILEAD SCIENCES INC 14.89 121.79B
VX1.DE VERTEX PHARMACEUTICALS INC 23.66 87.47B
ARGX.BR ARGENX SE 89.81 40.45B
22UA.DE BIONTECH SE-ADR N/A 21.07B
IDP.DE BIOGEN INC 8.93 17.84B
1MRNA.MI MODERNA INC N/A 8.17B
0QF.DE MODERNA INC N/A 8.15B
1EXAS.MI EXACT SCIENCES CORP N/A 7.29B
ABVX.PA ABIVAX SA N/A 5.90B
1VKTX.MI VIKING THERAPEUTICS INC N/A 2.41B

About AYJ.DE

Company Profile

AYJ logo image Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 700 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Company Info

VALNEVA SE

6 rue Alain Bombard

Saint-Herblain PAYS DE LA LOIRE FR

Employees: 700

AYJ Company Website

AYJ Investor Relations

Phone: 33228073710

VALNEVA SE / AYJ.DE FAQ

What is the stock price of VALNEVA SE today?

The current stock price of AYJ.DE is 3.8 EUR. The price increased by 6.68% in the last trading session.


What is the ticker symbol for VALNEVA SE stock?

The exchange symbol of VALNEVA SE is AYJ and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is AYJ.DE stock listed?

AYJ.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for VALNEVA SE stock?

12 analysts have analysed AYJ.DE and the average price target is 7.33 EUR. This implies a price increase of 92.81% is expected in the next year compared to the current price of 3.8. Check the VALNEVA SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is VALNEVA SE worth?

VALNEVA SE (AYJ.DE) has a market capitalization of 323.12M EUR. This makes AYJ.DE a Small Cap stock.


How many employees does VALNEVA SE have?

VALNEVA SE (AYJ.DE) currently has 700 employees.


What are the support and resistance levels for VALNEVA SE (AYJ.DE) stock?

VALNEVA SE (AYJ.DE) has a support level at 3.74 and a resistance level at 3.81. Check the full technical report for a detailed analysis of AYJ.DE support and resistance levels.


Is VALNEVA SE (AYJ.DE) expected to grow?

The Revenue of VALNEVA SE (AYJ.DE) is expected to grow by 4.03% in the next year. Check the estimates tab for more information on the AYJ.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy VALNEVA SE (AYJ.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VALNEVA SE (AYJ.DE) stock pay dividends?

AYJ.DE does not pay a dividend.


When does VALNEVA SE (AYJ.DE) report earnings?

VALNEVA SE (AYJ.DE) will report earnings on 2025-11-20.


What is the Price/Earnings (PE) ratio of VALNEVA SE (AYJ.DE)?

VALNEVA SE (AYJ.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.45).


AYJ.DE Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to AYJ.DE. When comparing the yearly performance of all stocks, AYJ.DE is one of the better performing stocks in the market, outperforming 92.4% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AYJ.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AYJ.DE. AYJ.DE may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AYJ.DE Financial Highlights

Over the last trailing twelve months AYJ.DE reported a non-GAAP Earnings per Share(EPS) of -0.45. The EPS decreased by -95.65% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.08%
ROA 7.48%
ROE 20.65%
Debt/Equity 1.06
Chartmill High Growth Momentum
EPS Q2Q%56.25%
Sales Q2Q%26.98%
EPS 1Y (TTM)-95.65%
Revenue 1Y (TTM)10.32%

AYJ.DE Forecast & Estimates

12 analysts have analysed AYJ.DE and the average price target is 7.33 EUR. This implies a price increase of 92.81% is expected in the next year compared to the current price of 3.8.

For the next year, analysts expect an EPS growth of -609.41% and a revenue growth 4.03% for AYJ.DE


Analysts
Analysts83.33
Price Target7.33 (92.89%)
EPS Next Y-609.41%
Revenue Next Year4.03%

AYJ.DE Ownership

Ownership
Inst Owners23.31%
Ins Owners0.22%
Short Float %N/A
Short RatioN/A